- Home
- OP vs NCNA Comparison
OP vs NCNA Comparison
Compare OP & NCNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OP
- NCNA
- Stock Information
- Founded
- OP 2021
- NCNA 1997
- Country
- OP Greece
- NCNA United Kingdom
- Employees
- OP N/A
- NCNA N/A
- Industry
- OP
- NCNA Biotechnology: Pharmaceutical Preparations
- Sector
- OP
- NCNA Health Care
- Exchange
- OP Nasdaq
- NCNA Nasdaq
- Market Cap
- OP 8.6M
- NCNA 7.6M
- IPO Year
- OP N/A
- NCNA 2017
- Fundamental
- Price
- OP $1.35
- NCNA $3.94
- Analyst Decision
- OP
- NCNA
- Analyst Count
- OP 0
- NCNA 0
- Target Price
- OP N/A
- NCNA N/A
- AVG Volume (30 Days)
- OP 788.6K
- NCNA 453.0K
- Earning Date
- OP 12-19-2025
- NCNA 11-24-2025
- Dividend Yield
- OP N/A
- NCNA N/A
- EPS Growth
- OP N/A
- NCNA N/A
- EPS
- OP N/A
- NCNA N/A
- Revenue
- OP $19,435,000.00
- NCNA N/A
- Revenue This Year
- OP N/A
- NCNA N/A
- Revenue Next Year
- OP N/A
- NCNA N/A
- P/E Ratio
- OP N/A
- NCNA N/A
- Revenue Growth
- OP N/A
- NCNA N/A
- 52 Week Low
- OP $1.07
- NCNA $2.78
- 52 Week High
- OP $79.25
- NCNA $332.00
- Technical
- Relative Strength Index (RSI)
- OP 44.23
- NCNA 42.49
- Support Level
- OP $1.28
- NCNA $3.71
- Resistance Level
- OP $2.38
- NCNA $4.07
- Average True Range (ATR)
- OP 0.22
- NCNA 0.39
- MACD
- OP -0.09
- NCNA -0.17
- Stochastic Oscillator
- OP 7.29
- NCNA 5.86
About OP OceanPal Inc.
OceanPal Inc is a provider of shipping transportation services. It specializes in the ownership of vessels. Each of its vessels is owned through a separate wholly-owned subsidiary. The company includes Dry Bulk segment and Tanker segment. Majority of revenue is Dry Bulk segment.
About NCNA NuCana plc
NuCana PLC is a biopharmaceutical company focused on improving treatment outcomes for cancer patients by ProTide technology. Utilizing proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. The company's ProTide pipeline products are NUC-3373, NUC-7738, Acelarin. Geographically operates through the region of the United States.